Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine in Intermittent Warm Blood Cardioplegia
NCT02681913Phase 2Unknown
- Sponsor
- Amphia Ziekenhuis
- Start
- Feb 2016
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of adenosine in Myocardial injury (2 arms), sponsored by Amphia Ziekenhuis. Primary endpoint: cardiac Troponin T release. Status: unknown.
02
Drugs
adenosine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on NCT02681913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02681913.